Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Apr;43(2):346-50.
doi: 10.1007/s12020-012-9741-9. Epub 2012 Jul 14.

Correlation of high urinary Smad1 level with glomerular hyperfiltration in type 2 diabetes mellitus

Affiliations

Correlation of high urinary Smad1 level with glomerular hyperfiltration in type 2 diabetes mellitus

Wen-Jin Fu et al. Endocrine. 2013 Apr.

Abstract

The aim of this study was to assess the relationship between urinary Smad1 and glomerular hyperfiltration (GHF) in type 2 diabetes mellitus (T2DM), and to explore the factors related to the urinary Smad1 in T2DM. The reference value of the estimated glomerular filtration rate (eGFR) was determined in 248 healthy individuals. 30 patients with GHF, 58 patients with norm-GFR T2DM, and 24 healthy patients who served as controls were recruited. Urinary Smad1, fasting plasma glucose (FPG), fasting serum C-Peptide (C-P), hemoglobin A1C (HbA1c), cystatin C, and other chemistry laboratory parameters of T2DM participants and controls were measured. Patients with GHF had higher levels of urinary Smad1 than the control group, and those with norm-GFR. For T2DM patients with body mass index, age, and gender adjustments, urinary Smad1 was positively correlated with FPG, HbA1C, and eGFR, but negatively correlated with fasting serum C-P. Multivariate linear regression analysis demonstrated that eGFR, HbA1C, and fasting serum C-P were independently associated with urinary Smad1. High levels of urinary Smad1 were found in GHF patients with T2DM, which may be another potential mechanism of GHF in relation to diabetic nephropathy.

PubMed Disclaimer

References

    1. Eur J Clin Invest. 2010 Feb;40(2):95-102 - PubMed
    1. Histol Histopathol. 2011 Apr;26(4):531-41 - PubMed
    1. Diabetes Res Clin Pract. 2012 Jan;95(1):105-9 - PubMed
    1. Cell. 1996 May 17;85(4):489-500 - PubMed
    1. Am J Physiol Renal Physiol. 2009 Mar;296(3):F614-21 - PubMed

Publication types

MeSH terms